| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 3.4 | $0-$5k | 0.00 |
Summary
A vulnerability described as problematic has been identified in IBM Rational Team Concert up to 4.0.0. This issue affects some unknown processing. Such manipulation leads to cross site scripting. This vulnerability is listed as CVE-2015-0122. The attack may be performed from remote. There is no available exploit. Upgrading the affected component is recommended.
Details
A vulnerability was found in IBM Rational Team Concert up to 4.0.0 and classified as problematic. Affected by this issue is an unknown code block. The manipulation with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is integrity. CVE summarizes:
Cross-site scripting (XSS) vulnerability in IBM Rational Team Concert 2.x and 3.x before 3.0.1.6 iFix 5, 4.x before 4.0.7 iFix3, and 5.x before 5.0.2 allows remote authenticated users to inject arbitrary web script or HTML via a crafted URL, a different vulnerability than CVE-2015-0123.
The weakness was presented 03/12/2015 (Website). The advisory is shared for download at www-01.ibm.com. This vulnerability is handled as CVE-2015-0122 since 11/18/2014. The attack may be launched remotely. The requirement for exploitation is a simple authentication. Successful exploitation requires user interaction by the victim. There are neither technical details nor an exploit publicly available. The MITRE ATT&CK project declares the attack technique as T1059.007.
Upgrading to version 4.0.1 eliminates this vulnerability.
The vulnerability is also documented in the databases at SecurityFocus (BID 73093†) and Vulnerability Center (SBV-51617†). See VDB-74409 for similar entry. VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Vendor
Name
Version
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 3.5VulDB Meta Temp Score: 3.4
VulDB Base Score: 3.5
VulDB Temp Score: 3.4
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔍
Upgrade: Rational Team Concert 4.0.1
Timeline
11/18/2014 🔍03/05/2015 🔍
03/05/2015 🔍
03/12/2015 🔍
03/12/2015 🔍
03/30/2015 🔍
07/28/2015 🔍
05/01/2022 🔍
Sources
Vendor: ibm.comAdvisory: www-01.ibm.com
Status: Not defined
Confirmation: 🔍
CVE: CVE-2015-0122 (🔍)
GCVE (CVE): GCVE-0-2015-0122
GCVE (VulDB): GCVE-100-74408
SecurityFocus: 73093 - IBM Rational Team Concert CVE-2015-0122 Unspecified HTML Injection Vulnerability
SecurityTracker: 1031884
Vulnerability Center: 51617 - IBM Rational Team Concert Remote XSS Vulnerability, Low
See also: 🔍
Entry
Created: 03/30/2015 12:36Updated: 05/01/2022 12:07
Changes: 03/30/2015 12:36 (49), 08/03/2017 03:21 (11), 05/01/2022 12:07 (3)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.